beta

AGIO

Agios Pharmaceuticals Inc.

Agio

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

Market Cap: 4.5 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.agios.com

Shares Outstanding: 55.7 Million

Float: 55 Million

Dividend: 0.0 (0.0%)

Beta: 2.237777

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 6.72 Million

Ethical Flags

Animal testing

Longest drawdown: 1200 trading days

From: 2015-01-14 To: 2019-10-17

Lowest Point:

Key events next week - healthcare

via: SeekingAlpha at 2019-06-13 03:28:10:000

Noteworthy events during the week of June 16 - 22 for healthcare investors. More news on: ProMIS Neurosciences, Inc., Merck & Co., Inc., IQVIA Holdings Inc., Healthcare stocks news, , Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud